Cinnamon's secret weapon—Could it fight Alzheimer's disease?
A common compound in cinnamon, cinnamaldehyde, shows promise for Alzheimer's treatment. Researchers found it reduces amyloid levels in the blood. This discovery offers a potential new avenue for battling the devastating neurodegenerative disease.
The study, published in Scientific Reports, highlights cinnamaldehyde's ability to lower amyloid-beta. Amyloid-beta is a protein linked to Alzheimer's development and progression. Over 7 million Americans currently live with Alzheimer's, according to the Alzheimer's Association.
Scientists observed significant reductions in amyloid levels in participants taking cinnamaldehyde. This suggests a possible therapeutic effect for preventing or slowing Alzheimer's. Further research is needed to confirm these findings in human trials.
This breakthrough could lead to natural, accessible treatments for Alzheimer's. Future studies will explore optimal dosages and long-term effects of cinnamaldehyde.
